WithdrawnNot applicableNCT03408561

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

This pilot clinical trial studies how well social media listening works in improving clinical trial recruitment in patients with cancer. Social media listening and recruitment on Twitter may enhance enrollment for cancer-related clinical trials.

Checked against the public recordLast updated Sep 17, 2019 · Source: ClinicalTrials.gov

StatusWithdrawn
PhaseNot applicable
U.S. locations1
SponsorUniversity of Southern California
01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
University of Southern California
Interventions being studied
Other: Internet-Based Intervention; Other: Survey Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * TRIAL INCLUSION: * Focus on one of the following disease categories: non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, kidney cancer, lymphoma * Be a phase 1 trial in expansion, phase 2, or 3 * Be interventional trials * Recruit in English * Be Institutional Review Board (IRB)-approved and open to accrual at USC Norris * Recruit for at least 9 months at the point of enrollment * Set monthly accrual target \>= 1/ and annual accrual target \>= 12 * PATIENT INCLUSION: * Will include all prospective trial participants in this study that come from Twitter in response of our SM recruitment interventions, provided they meet the specific trial's eligibility criteria Exclusion Criteria: * TRIAL EXCLUSION: * Phase 1 trials in dose escalation * PATIENT EXCLUSION: * Persons who do not meet the eligibility criteria of any of the trials open to accrual will be excluded from participation, and persons who may be eligible (e.g., disease/histology, stage, prior treatment) but do not meet additional trial-specific requirements such as insurance or allergy to drug)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • USC / Norris Comprehensive Cancer CenterLos Angeles, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 17, 2019. Always confirm current availability with the study team.

View original record ↗